Maud-Emmanuelle Gilles

Cobomarsen, an Oligonucleotide Inhibitor of miR-155, Slows DLBCL Tumor Cell Growth <i>In Vitro</i> and <i>In Vivo</i>

Eleni Anastasiadou, Anita G. Seto, Xuan Beatty et al. · Clinical Cancer Research · 2020 · 150 citations · Full text

Medicine, Oncology, Pharmacology +14

Nucleolin Targeting Impairs the Progression of Pancreatic Cancer and Promotes the Normalization of Tumor Vasculature

Maud-Emmanuelle Gilles, Federica Maione, Mélissande Cossutta et al. · Cancer Research · 2016 · 129 citations · Full text

Medicine, Oncology, Pharmacology +16

Personalized RNA Medicine for Pancreatic Cancer

Maud-Emmanuelle Gilles, Liangliang Hao, Ling Huang et al. · Clinical Cancer Research · 2018 · 71 citations · Full text

Medicine, Oncology, Translational Sciences +17

Xist RNA antagonizes the SWI/SNF chromatin remodeler BRG1 on the inactive X chromosome

Teddy Jégu, Roy Blum, Jesse C. Cochrane et al. · Nature Structural & Molecular Biology · 2019 · 67 citations

Life Sciences, Genetics, Molecular Biology +13

Hydrophobically Modified let-7b miRNA Enhances Biodistribution to NSCLC and Downregulates HMGA2 In Vivo

Meirav Segal, Annabelle Biscans, Maud-Emmanuelle Gilles et al. · Molecular Therapy — Nucleic Acids · 2019 · 58 citations · Full text

Life Sciences, Molecular Biology, Oncology +17